Asthma is a chronic respiratory condition that affects millions of people worldwide, and for some, the symptoms are severe and difficult to manage with standard therapies. Severe asthma can lead to frequent flare-ups, hospital visits, and a diminished quality of life. In recent years, new biologic treatments have emerged to provide relief to those struggling with uncontrolled asthma. One of these treatments is Fasenra, a targeted therapy designed specifically for patients with severe eosinophilic asthma.<\/p>\n
This article explains how Fasenra works for asthma, what patients can expect from treatment, potential Fasenra side effects, and important information about Fasenra dosing and administration.<\/p>\n
Asthma occurs when the airways become inflamed and narrowed, making it hard to breathe. In severe eosinophilic asthma, a high number of eosinophils\u2014white blood cells involved in immune response\u2014cause persistent inflammation in the lungs. This leads to frequent asthma attacks, coughing, wheezing, and shortness of breath.<\/p>\n
Traditional inhalers and corticosteroids may not provide sufficient control for patients with this condition. That\u2019s where biologics like Fasenra for asthma come in.<\/p>\n
Fasenra (benralizumab) is a monoclonal antibody designed to reduce the number of eosinophils in the blood and airways. It is administered as a Fasenra injection<\/a> and specifically targets the interleukin-5 receptor (IL-5R\u03b1) on eosinophils. By binding to this receptor, Fasenra attracts natural killer cells that directly deplete eosinophils, helping reduce inflammation in the lungs.<\/p>\n This unique mechanism makes Fasenra one of the most effective treatments for patients whose asthma is driven by eosinophilic inflammation.<\/p>\n Fasenra works by disrupting the inflammatory process that drives severe asthma symptoms:<\/p>\n Eosinophils are a key cause of airway inflammation. Fasenra directly attaches to IL-5 receptors on eosinophils.<\/p>\n Once attached, it activates natural killer cells, which eliminate eosinophils from the bloodstream and airways.<\/p>\n With fewer eosinophils present, the airways remain more open, reducing flare-ups, coughing, and wheezing.<\/p>\n Many patients report fewer asthma exacerbations, reduced hospital visits, and improved lung function over time.<\/p>\n Clinical studies have shown that patients using Fasenra for asthma<\/a> experienced significant reductions in the frequency of severe asthma attacks compared to standard treatments alone.<\/p>\n Fasenra is not taken daily like an inhaler. Instead, it is given as a subcutaneous Fasenra injection (under the skin).<\/p>\n This convenient Fasenra dosing schedule makes it easier for patients to maintain treatment compared to other biologics that require more frequent administration.<\/p>\n Injections are usually administered by a healthcare professional, although some patients may be trained to self-administer at home with a prefilled syringe or autoinjector.<\/p>\n Like any medication, Fasenra may cause side effects, though not everyone experiences them. Common Fasenra side effects<\/a> include:<\/p>\n Most side effects are mild and manageable, but patients should always report new or worsening symptoms to their healthcare provider.<\/p>\n Fasenra<\/a> is approved for patients 12 years and older who have severe eosinophilic asthma that remains uncontrolled despite high-dose inhaled corticosteroids and other long-term treatments.<\/p>\n It is not meant for sudden asthma attacks or as a rescue inhaler replacement. Instead, it is part of a long-term asthma management plan.<\/p>\n Patients with frequent hospitalizations, persistent symptoms, or elevated eosinophil counts in blood tests are often considered candidates for Fasenra for asthma therapy.<\/p>\n Before beginning treatment, patients should discuss the following with their doctor:<\/p>\n Severe eosinophilic asthma can be overwhelming and life-limiting, but treatments like Fasenra for asthma provide new hope. By targeting eosinophils directly, Fasenra reduces airway inflammation, helps prevent flare-ups, and improves overall lung function. With its convenient Fasenra dosing<\/a> schedule and proven effectiveness, it has become a leading therapy for patients struggling with uncontrolled asthma. However, like all medications, it comes with potential Fasenra side effects and should only be used under a doctor\u2019s guidance. Patients considering this therapy should consult their healthcare provider to determine if Fasenra injection is the right choice for them.<\/p>\n Fasenra is used to treat severe eosinophilic asthma in patients who do not respond well to traditional inhalers and corticosteroids.<\/p>\n Fasenra is given as a subcutaneous injection every 4 weeks for the first 3 doses, then once every 8 weeks.<\/p>\n Yes. Some patients may self-inject Fasenra at home with proper training, using prefilled syringes or autoinjectors.<\/p>\n Common side effects include headache, sore throat, fever, and injection site reactions. Rarely, serious allergic reactions may occur.<\/p>\n Many patients notice improvements within a few weeks, but full benefits may take several months of consistent treatment.<\/p>\n <\/p>\n Better breathing starts with Fasenra. Visit our website https:\/\/americaninfusioncare.com\/treatment-and-care\/available-therapies\/<\/a> now or call us at +1 832-447-6454<\/a> to explore your options.<\/p>\n","protected":false},"excerpt":{"rendered":" Patients with severe asthma may find relief with Fasenra, a prescription option that targets eosinophils to provide long-term control of symptoms.<\/p>\n","protected":false},"author":3,"featured_media":366,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-365","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-post"],"_links":{"self":[{"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/posts\/365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/comments?post=365"}],"version-history":[{"count":1,"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/posts\/365\/revisions"}],"predecessor-version":[{"id":367,"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/posts\/365\/revisions\/367"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/media\/366"}],"wp:attachment":[{"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/media?parent=365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/categories?post=365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/americaninfusioncare.com\/blogs\/wp-json\/wp\/v2\/tags?post=365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}How Fasenra Works for Severe Asthma Patients<\/h2>\n
1. Targeting Eosinophils:<\/h3>\n
2. Reducing Inflammation:<\/h3>\n
3. Improved Breathing:<\/h3>\n
4. Long-Term Benefits:<\/h3>\n
Fasenra Dosing and Administration<\/h2>\n
\n
Fasenra Side Effects<\/h2>\n
\n
Who Can Benefit from Fasenra?<\/h2>\n
Advantages of Fasenra for Asthma Patients<\/h2>\n
\n
Considerations Before Starting Fasenra<\/h2>\n
\n
Conclusion<\/h2>\n
Frequently Asked Questions (FAQs)<\/h2>\n
1. What is Fasenra used for?<\/h5>\n
2. How is Fasenra given?<\/h5>\n
3. Can I self-administer Fasenra?<\/h5>\n
4. What are the common Fasenra side effects?<\/h5>\n
5. How long does it take for Fasenra to work?<\/h5>\n